The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p
Authors
Keywords
Osteoarthritis, Chondrocyte hypertrophy, miR-149-5p, JAK inhibitor (tofacitinib), Therapeutics
Journal
BONE
Volume 151, Issue -, Pages 116024
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.bone.2021.116024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-15a-5p Regulates the Development of Osteoarthritis by Targeting PTHrP in Chondrocytes
- (2019) Zhi-xi Duan et al. Biomed Research International
- Loss ofFgfr1in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint
- (2018) Zuqiang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling
- (2018) Feng-Lai Yuan et al. Frontiers in Physiology
- MicroRNAs and Osteoarthritis
- (2018) Charles Malemud Cells
- Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model
- (2017) Shi-Cong Tao et al. Theranostics
- Osteoarthritis: toward a comprehensive understanding of pathological mechanism
- (2017) Di Chen et al. Bone Research
- The Role of MicroRNAs and Their Targets in Osteoarthritis
- (2016) Gregory R. Sondag et al. Current Rheumatology Reports
- Osteoblast-derived microvesicles: A novel mechanism for communication between osteoblasts and osteoclasts
- (2015) Lili Deng et al. BONE
- Biologic basis of osteoarthritis
- (2015) Charles J. Malemud CURRENT OPINION IN RHEUMATOLOGY
- p21 deficiency is susceptible to osteoarthritis through STAT3 phosphorylation
- (2015) Shinya Hayashi et al. ARTHRITIS RESEARCH & THERAPY
- Tofacitinib
- (2014) Deepti Vyas et al. ANNALS OF PHARMACOTHERAPY
- Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling
- (2014) Yun-peng Zhao et al. ANNALS OF THE RHEUMATIC DISEASES
- Ginseng saponins and the treatment of osteoporosis: mini literature review
- (2013) Muhammad Hanif Siddiqi et al. Journal of Ginseng Research
- The Role of Changes in Extracellular Matrix of Cartilage in the Presence of Inflammation on the Pathology of Osteoarthritis
- (2013) Maricela Maldonado et al. Biomed Research International
- Homeostatic Mechanisms in Articular Cartilage and Role of Inflammation in Osteoarthritis
- (2013) Xavier Houard et al. Current Rheumatology Reports
- Osteoarthritis: A disease of the joint as an organ
- (2012) Richard F. Loeser et al. ARTHRITIS AND RHEUMATISM
- The role of synovitis in osteoarthritis pathogenesis
- (2012) Carla R. Scanzello et al. BONE
- Pervasive roles of microRNAs in cardiovascular biology
- (2011) Eric M. Small et al. NATURE
- Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes
- (2010) Frank Beier et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse
- (2010) S.S. Glasson et al. OSTEOARTHRITIS AND CARTILAGE
- Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway
- (2009) Xiumin Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy
- (2008) Alison R. Hayman AUTOIMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started